Showing 2101-2110 of 2314 results for "".
- Adverum Biotechnologies Reports Positive Interim Data of ADVM-022 Intravitreal Gene Therapy for Wet AMDhttps://modernod.com/news/adverum-biotechnologies-reports-positive-interim-data-of-advm-022-intravitreal-gene-therapy-for-wet-amd/2477705/Adverum Biotechnologies announced new interim clinical data from Cohorts 1-3 of the OPTIC phase 1 dose-ranging clinical trial of ADVM-022 intravitreal (IVT) injection gene therapy in patients requiring frequent anti-VEGF injections for their wet age-related macular degeneration (AMD) and provided
- An Imaging Method To Help Us See Behind Our Eyeshttps://modernod.com/news/an-imaging-method-to-help-us-see-behind-our-eyes/2477684/The choroidal and retrobulbar blood vessels sit at the deep region of our eyes, supplying oxygen and nutrients to the retina. They are vital to our vision and the health and structure of our eyes. However, we don’t understand these important blood vessels as well as we should, because current ima
- Quest Diagnostics Launches First Consumer-Ordered COVID-19 Antibody Testhttps://modernod.com/news/quest-diagnostics-launches-first-consumer-ordered-covid-19-antibody-test/2477674/For about $120, anyone can get now get a COVID-19 antibody test from Quest Diagnostics. The lab company announced Tuesday it launched the first consumer-ordered test—yes, that means there’s no doctor referral needed—to allow patients to check whether they have the antibodies that indicate t
- Gilead Says Early Results of Coronavirus Drug Trial Show Improvement With Shorter Remdesivir Treatmenthttps://modernod.com/news/gilead-says-early-results-of-coronavirus-drug-trial-show-improvement-with-shorter-remdesivir-treatment/2477673/Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks, according to a CNBC
- AAPS: Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patientshttps://modernod.com/news/aaps-hydroxychloroquine-has-about-90-percent-chance-of-helping-covid-19-patients/2477670/In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presented a
- WHO Accidently Leaks Disappointing Results of Chinese Clinical Trial Testing Gilead’s Remdesivir in Severe COVID-19https://modernod.com/news/who-accidently-leaks-disappointing-results-of-chinese-clinical-trial-testing-gileads-remdesivir-in-severe-covid-19/2477645/According to a draft document published in error by the World Health Organization (WHO), Gilead Sciences’ remdesivir failed to improve the condition of patients with severe COVID-19 participating in a Chinese clinical trial, nor was the drug found to reduce the virus’ presence in the
- Researchers Look To Behavior To Explore Why The Coronavirus May Hit Men Harderhttps://modernod.com/news/researchers-look-to-behavior-to-explore-why-the-coronavirus-may-hit-men-harder/2477641/Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women. But experts don’t know why. At Johns Hopkins University, researchers have begun to
- NIH to Launch Public-Private Partnership to Speed COVID-19 Vaccine and Treatment Optionshttps://modernod.com/news/nih-to-launch-public-private-partnership-to-speed-covid-19-vaccine-and-treatment-options/2477612/The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, along with the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Preven
- CMS Boosts Medicare Payments for High-Throughput COVID-19 Diagnostic Testshttps://modernod.com/news/cms-boosts-medicare-payments-for-high-throughput-covid-19-diagnostic-tests/2477597/The Trump administration will nearly double payments for high-throughput technology that can rapidly test and diagnose COVID-19 cases, according to a FierceHealthcare
- TearClear Appoints Robert J. Dempsey Chief Executive Officerhttps://modernod.com/news/tearclear-appoints-robert-j-dempsey-chief-executive-officer/2477596/TearClear announced the appointment of Robert J. Dempsey as Chief Executive Officer. TearClear is the only pharmaceutical company to administer preservative free eye drops to the ocular surface, that are preserved safely prior to dosing, according to a company news release. <